These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23111389)

  • 1. MiR-93 enhances angiogenesis and metastasis by targeting LATS2.
    Fang L; Du WW; Yang W; Rutnam ZJ; Peng C; Li H; O'Malley YQ; Askeland RW; Sugg S; Liu M; Mehta T; Deng Z; Yang BB
    Cell Cycle; 2012 Dec; 11(23):4352-65. PubMed ID: 23111389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8.
    Fang L; Deng Z; Shatseva T; Yang J; Peng C; Du WW; Yee AJ; Ang LC; He C; Shan SW; Yang BB
    Oncogene; 2011 Feb; 30(7):806-21. PubMed ID: 20956944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-135b, upregulated in breast cancer, promotes cell growth and disrupts the cell cycle by regulating LATS2.
    Hua K; Jin J; Zhao J; Song J; Song H; Li D; Maskey N; Zhao B; Wu C; Xu H; Fang L
    Int J Oncol; 2016 May; 48(5):1997-2006. PubMed ID: 26934863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-25 Promotes Cell Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Targeting the LATS2/YAP Signaling Pathway.
    Wu T; Hu H; Zhang T; Jiang L; Li X; Liu S; Zheng C; Yan G; Chen W; Ning Y; Li Y; Lu Z
    Oxid Med Cell Longev; 2019; 2019():9719723. PubMed ID: 31316723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma.
    Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H
    J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of MiR-10b Restrains the Migration and Epithelial-Mesenchymal Transition of Lung Cells by Targeting LATS2 via TAZ Pathway.
    Yang Y; Wang J
    Med Sci Monit; 2020 May; 26():e920275. PubMed ID: 32361707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoliquiritigenin suppresses the proliferation and induced apoptosis via miR-32/LATS2/Wnt in nasopharyngeal carcinoma.
    Wang TT; Chen ZZ; Xie P; Zhang WJ; Du MY; Liu YT; Zhu HY; Guo YS
    Eur J Pharmacol; 2019 Aug; 856():172352. PubMed ID: 31004603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer.
    Lee KH; Goan YG; Hsiao M; Lee CH; Jian SH; Lin JT; Chen YL; Lu PJ
    Exp Cell Res; 2009 Sep; 315(15):2529-38. PubMed ID: 19501585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LATS2 as a poor prognostic marker regulates non-small cell lung cancer invasion by modulating MMPs expression.
    Wu A; Li J; Wu K; Mo Y; Luo Y; Ye H; Mai Z; Guo K; Wang Y; Li S; Chen H; Luo W; Yang Z
    Biomed Pharmacother; 2016 Aug; 82():290-7. PubMed ID: 27470365
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circular RNA circ_0001368 inhibited growth and invasion in renal cell carcinoma by sponging miR-492 and targeting LATS2.
    Chen L; Wu D; Ding T
    Gene; 2020 Aug; 753():144781. PubMed ID: 32428698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Downregulation of microRNA-224-3p Hampers Retinoblastoma Progression via Activation of the Hippo-YAP Signaling Pathway by Increasing LATS2.
    Song L; Huang Y; Zhang X; Han S; Hou M; Li H
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):32. PubMed ID: 32186675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-92 overexpression suppresses immune cell function in ovarian cancer via LATS2/YAP1/PD-L1 pathway.
    Feng S; Sun H; Zhu W
    Clin Transl Oncol; 2021 Mar; 23(3):450-458. PubMed ID: 32654106
    [TBL] [Abstract][Full Text] [Related]  

  • 13. circRNA_0000140 suppresses oral squamous cell carcinoma growth and metastasis by targeting miR-31 to inhibit Hippo signaling pathway.
    Peng QS; Cheng YN; Zhang WB; Fan H; Mao QH; Xu P
    Cell Death Dis; 2020 Feb; 11(2):112. PubMed ID: 32041942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-650 Promotes the Metastasis and Epithelial-Mesenchymal Transition of Hepatocellular Carcinoma by Directly Inhibiting LATS2 Expression.
    Han LL; Yin XR; Zhang SQ
    Cell Physiol Biochem; 2018; 51(3):1179-1192. PubMed ID: 30481780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer-derived exosomal miR-106b-3p promotes metastasis by down-regulating DLC-1 expression.
    Liu H; Liu Y; Sun P; Leng K; Xu Y; Mei L; Han P; Zhang B; Yao K; Li C; Bai J; Cui B
    Clin Sci (Lond); 2020 Feb; 134(4):419-434. PubMed ID: 32065214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MIR22HG inhibits breast cancer progression by stabilizing LATS2 tumor suppressor.
    Deng X; Ye D; Hua K; Song H; Luo Q; Munankarmy A; Liu D; Zhou B; Zheng W; Zhou X; Ji C; Wang X; Yu Y; Fang L
    Cell Death Dis; 2021 Aug; 12(9):810. PubMed ID: 34446703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression.
    Fang JH; Zhou HC; Zeng C; Yang J; Liu Y; Huang X; Zhang JP; Guan XY; Zhuang SM
    Hepatology; 2011 Nov; 54(5):1729-40. PubMed ID: 21793034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LINC00689 participates in proliferation, chemoresistance and metastasis via miR-31-5p/YAP/β-catenin axis in colorectal cancer.
    Du YL; Liang Y; Shi GQ; Cao Y; Qiu J; Yuan L; Yong Z; Liu L; Li J
    Exp Cell Res; 2020 Oct; 395(1):112176. PubMed ID: 32682784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance.
    Guo Y; Cui J; Ji Z; Cheng C; Zhang K; Zhang C; Chu M; Zhao Q; Yu Z; Zhang Y; Fang YX; Gao WQ; Zhu HH
    Oncogene; 2017 Nov; 36(45):6336-6347. PubMed ID: 28745315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MiR-135b is a novel oncogenic factor in cutaneous melanoma by targeting LATS2.
    Hu Y; Wang Q; Zhu XH
    Melanoma Res; 2019 Apr; 29(2):119-125. PubMed ID: 30480622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.